4.2 Article

Attenuation of Liver Injury via Bicyclol-Bovine Serum Albumin Nanopreparation using a Green Synthetic Approach

Related references

Note: Only part of the references are listed.
Article Plant Sciences

Schisandrol A, the main active ingredient of Schisandrae Chinensis Fructus, inhibits pulmonary fibrosis through suppression of the TGF- β signaling pathway as revealed by UPLC-Q-TOF/MS, network pharmacology and experimental verification

Zhenghua Wu et al.

Summary: This study identified the absorbed active ingredients and metabolites of Schisandra in rat plasma, and illuminated its biological mechanism of treatment for idiopathic pulmonary fibrosis through experimental and network pharmacology investigation.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

Article Chemistry, Multidisciplinary

Nanoencapsulation as a Promising Platform for the Delivery of the Morin-Cu(II) Complex: Antibacterial and Anticancer Potential

Pooja Ghosh et al.

Summary: Nanoencapsulation is a promising approach for delivering poorly aqueous soluble compounds. In this study, HSA-based and PLGA-based nanoparticles were prepared to deliver the morin-Cu(II) complex. The nanoparticles showed controlled release, antioxidant activity, antibacterial activity, and anticancer activity, making them potential delivery systems for the morin-Cu(II) complex.

ACS OMEGA (2022)

Review Pharmacology & Pharmacy

Pharmacodynamic effects and molecular mechanisms of lignans from Schisandra chinensis Turcz. (Baill.), a current review

Yuan Zhou et al.

Summary: Schisandra chinensis, a traditional herbal medicine, is commonly used in the treatment of liver and neurological diseases. Modern research has highlighted lignans as its main active ingredients, showing antioxidant, anti-inflammatory, and neuroprotective properties, as well as potential effects in cancer and fibrosis.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Immunology

Therapeutic potential of bicyclol in liver diseases: Lessons from a synthetic drug based on herbal derivative in traditional Chinese medicine

Tianming Zhao et al.

Summary: Bicyclol, a novel chemical drug derived from Schisandra chinensis, shows therapeutic potential in various liver conditions with a wide range of pharmacological properties. Pharmacokinetic studies indicate its safety and lack of drug interactions, making it a potential candidate for liver diseases worldwide. Further research is needed to understand its molecular mechanisms for increased potency in clinical use.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Medicine, Research & Experimental

Bicyclol for the treatment of drug-induced liver injury: a propensity score matching analysis using a nationwide inpatient database

Yongfeng Wang et al.

Summary: The study evaluated the efficacy and safety of bicyclol in patients with drug-induced liver injury using a nationwide database. Bicyclol showed a higher ALT normalization rate compared to the control group, with factors such as treatment drug and time interval between ALT tests influencing ALT recovery. There were no significant differences in renal function impairment or blood abnormalities between the two groups.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)

Article Chemistry, Multidisciplinary

A supramolecular nanocarrier for efficient cancer imaging and therapy by targeting at matriptase

Libin Jiang et al.

Summary: A novel matriptase targeting carrier (MTC) was designed, showed high specificity and cytotoxicity for matriptase-overexpressing cancer cells in vitro, and demonstrated potential as a highly efficient tumor targeting drug carrier for imaging and therapy.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Polymer Science

Cefotaxime Loaded Polycaprolactone Based Polymeric Nanoparticles with Antifouling Properties for In-Vitro Drug Release Applications

Sana Javaid et al.

Summary: This study successfully achieved the encapsulation of a therapeutic agent for antifouling functionality using nanotechnology. The drug-loaded nanoparticles showed potential for in vitro drug release and antifouling applications after optimization.

POLYMERS (2021)

Article Engineering, Biomedical

Microemulsion and bovine serum albumin nanoparticles as a novel hybrid nanocarrier system for efficient multifunctional drug delivery

Mahmoud Gharbavi et al.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2020)

Article Pharmacology & Pharmacy

Comparison and identification of metabolic profiling of bicyclol in rats, dogs and humans in vitro and in vivo

Minwan Hu et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Review Biochemistry & Molecular Biology

Progress to Improve Oral Bioavailability and Beneficial Effects of Resveratrol

Adele Chimento et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Chemistry, Multidisciplinary

Nanoencapsulation of carotenoids within lipid-based nanocarriers

Hadis Rostamabadi et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Article Nanoscience & Nanotechnology

Self-Templated, Green-Synthetic, Size-Controlled Protein Nanoassembly as a Robust Nanoplatform for Biomedical Application

Ya Wen et al.

ACS APPLIED MATERIALS & INTERFACES (2018)

Article Chemistry, Multidisciplinary

Minimalist Nanovaccine Constituted from Near Whole Antigen for Cancer Immunotherapy

Kun Wang et al.

ACS NANO (2018)

Article Medicine, Research & Experimental

Bicyclol exerts an anti-tumor effect via ROS-mediated endoplasmic reticulum stress in human renal cell carcinoma cells

Jing Wu et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Review Chemistry, Multidisciplinary

Albumin-based nanoparticles as potential controlled release drug delivery systems

Ahmed O. Elzoghby et al.

JOURNAL OF CONTROLLED RELEASE (2012)

Article Pharmacology & Pharmacy

A study of intestinal absorption of bicyclol in rats: Active efflux transport and metabolism as causes of its poor bioavailability

Wei Tan et al.

JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2008)

Article Gastroenterology & Hepatology

Toxicity of novel anti-hepatitis drug bicyclol: A preclinical study

Geng-Tao Liu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2005)